User contributions for Palmdoc
From OncoWiki
Jump to navigationJump to search
27 August 2018
- 05:2205:22, 27 August 2018 diff hist +1,614 SMILE No edit summary current
- 01:4401:44, 27 August 2018 diff hist +10 m Lymphoma Hodgkin's, Adult →Frontline current
14 June 2017
- 13:0613:06, 14 June 2017 diff hist +931 N BeGeV Created page with "== Hodgkin disease == salvage regimen in relapsed Hodgkin's lymphoma == Regimen == phase II study * Gemcitabine 800 mg/m2 on days 1 and 4 * Vinorelbine 20 mg/m2 on day 1, *..." current
- 12:5712:57, 14 June 2017 diff hist +14 Lymphoma Hodgkin's, Adult →Salvage
21 September 2016
- 02:0302:03, 21 September 2016 diff hist +593 Flu Bu ATG - Slavin No edit summary current
- 02:0202:02, 21 September 2016 diff hist +316 N Flu Bu ATG - Slavin Created page with "*Fludarabine (Fludara) 30 mg/m<sup>2</sup> IV once per day on days -10 to -5 (6 consecutive days) *Busulfan (Myleran) 4 mg/kg/day PO on days -6 to -5 (2 consecutive da..."
- 01:5501:55, 21 September 2016 diff hist +1 m Stem Cell Transplantation →Non-myeloablative conditioning regimens current
- 01:5401:54, 21 September 2016 diff hist +23 Stem Cell Transplantation →Non-myeloablative conditioning regimens
6 July 2016
- 20:2120:21, 6 July 2016 diff hist +2,303 N Flu Bu ATG for Haplo Created page with "== Regimen == *Busulfan (Busulfex, Otsuka Pharmaceuticals) 3.2 mg/kg per day intravenously on days −7 and −6 *Fludarabine 30 mg/m2 per day intravenously on days −7 to..." current
- 20:0720:07, 6 July 2016 diff hist +1 m Stem Cell Transplantation →Non-myeloablative conditioning regimens
- 20:0620:06, 6 July 2016 diff hist +25 Stem Cell Transplantation →Non-myeloablative conditioning regimens
16 May 2016
- 21:5221:52, 16 May 2016 diff hist +1,666 N R-MPV Created page with "== Regimen == IV Rituximab 500 mg/m2 day 1 IV Methotrexate 3.5 mg/m2 (over 2hours) day 2 IV Vincristine 1.4 mg/m2 (capped at 2.8mg)day 2 Procarbazine 100 mg/m2 /day was gi..." current
- 21:4521:45, 16 May 2016 diff hist +4 m Lymphoma Non-Hodgkin's, Adult →Primary CNS Lymphoma current
- 21:4421:44, 16 May 2016 diff hist +10 Lymphoma Non-Hodgkin's, Adult →Primary CNS Lymphoma
18 April 2016
- 02:1802:18, 18 April 2016 diff hist +1,734 N VDT-PACE VDTPACE current
- 01:5001:50, 18 April 2016 diff hist +1 m Multiple Myeloma And Plasma Cell Dyscrasias →Combinations current
- 01:5001:50, 18 April 2016 diff hist +13 m Multiple Myeloma And Plasma Cell Dyscrasias No edit summary
1 May 2014
- 22:0122:01, 1 May 2014 diff hist +35 m Lymphoma Non-Hodgkin's, Adult →Aggressive NHL
- 21:5421:54, 1 May 2014 diff hist +113 m Brentuximab vedotin →Brentuximab vedotin (Adcetris) current
- 21:5321:53, 1 May 2014 diff hist +1,048 m Brentuximab vedotin →Regimen
- 21:5021:50, 1 May 2014 diff hist +334 N Brentuximab vedotin Created page with "==Brentuximab vedotin (Adcetris)== ===Regimen=== *Brentuximab vedotin (Adcetris) 1.8 mg/kg IV over 30 minutes on day 1 Supportive medications: *Rothe et al. 2012: "no p..."
- 21:4921:49, 1 May 2014 diff hist +28 m Lymphoma Hodgkin's, Adult →Salvage
30 October 2013
- 03:3603:36, 30 October 2013 diff hist −25 m Adrenocortical Carcinoma No edit summary current
- 03:3503:35, 30 October 2013 diff hist +25 m Adrenocortical Carcinoma No edit summary
- 03:1603:16, 30 October 2013 diff hist +52 m Adrenocortical Carcinoma →References
- 03:1303:13, 30 October 2013 diff hist −61 m Adrenocortical Carcinoma →References
- 03:1203:12, 30 October 2013 diff hist +127 m Adrenocortical Carcinoma →References
- 03:1003:10, 30 October 2013 diff hist +879 m Adrenocortical Carcinoma →References
- 03:0703:07, 30 October 2013 diff hist +344 m Adrenocortical Carcinoma No edit summary
- 03:0103:01, 30 October 2013 diff hist +128 m Adrenocortical Carcinoma No edit summary
- 02:4402:44, 30 October 2013 diff hist +822 Adrenocortical Carcinoma →Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy
- 02:4302:43, 30 October 2013 diff hist +803 m Adrenocortical Carcinoma →Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy
- 02:4102:41, 30 October 2013 diff hist +67 N Adrenocortical Carcinoma Created page with "=Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy="
- 02:3402:34, 30 October 2013 diff hist +642 N OncoWiki:General disclaimer Created page with "Information on this website is meant only for Healthcare Practitioners. Use of any information obtained from this website is entirely at the user's discretion. You are advised..." current
- 02:3402:34, 30 October 2013 diff hist +192 N OncoWiki:About Created page with "This site will serve as a free repository for oncology information, chemotherapy protocols and cancer treatment regimens and is meant for Healthcare providers working in the f..." current
26 October 2013
- 09:4609:46, 26 October 2013 diff hist +26 Main Page No edit summary current
29 August 2013
- 07:2807:28, 29 August 2013 diff hist +5 m EPOCH-DA →References current
- 07:2107:21, 29 August 2013 diff hist +759 m EPOCH-DA No edit summary
- 07:2007:20, 29 August 2013 diff hist +20 m EPOCH-DA →Dose adjustments
- 07:1907:19, 29 August 2013 diff hist +405 m EPOCH-DA No edit summary
- 07:1807:18, 29 August 2013 diff hist +5 m EPOCH-DA →Supportive medications
- 07:1607:16, 29 August 2013 diff hist +5 m EPOCH-DA →Supportive medications
- 07:1607:16, 29 August 2013 diff hist +117 m EPOCH-DA →Supportive medications
- 07:1507:15, 29 August 2013 diff hist +113 m EPOCH-DA →Supportive medications
- 07:1507:15, 29 August 2013 diff hist +31 EPOCH-DA →Regimen
- 07:1407:14, 29 August 2013 diff hist +32 m EPOCH-DA →Regimen
- 07:1407:14, 29 August 2013 diff hist +169 m EPOCH-DA →Regimen
- 07:1307:13, 29 August 2013 diff hist +114 m EPOCH-DA →Regimen
- 07:0507:05, 29 August 2013 diff hist +45 m EPOCH-DA →Regimen
- 07:0407:04, 29 August 2013 diff hist +110 m EPOCH-DA →Regimen
- 07:0307:03, 29 August 2013 diff hist +82 m EPOCH-DA →Regimen
- 07:0207:02, 29 August 2013 diff hist +45 N EPOCH-DA Created page with "== Regimen == R-EPOCH-DA: Dose Adjusted EPOCH"
- 06:5306:53, 29 August 2013 diff hist +17 Lymphoma Non-Hodgkin's, Adult →Aggressive NHL
16 August 2013
- 09:3109:31, 16 August 2013 diff hist +1 Clofarabine, cyclophosphamide and etoposide →Regimen current
9 October 2012
- 03:5803:58, 9 October 2012 diff hist +66 Acute Myeloid Leukemia,Adult →Post-remission regimens current
- 03:5703:57, 9 October 2012 diff hist +47 Acute Myeloid Leukemia,Adult →Induction regimens
- 03:5703:57, 9 October 2012 diff hist +1,430 N Cytarabine Idarubicin Vorinostat induction Created page with "==Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) induction== ===Regimen=== *Vorinostat (Zolinza) 500 mg PO TID on days 1-3 *Cytarabine (Cytosar) 150..." current
- 03:5603:56, 9 October 2012 diff hist +1,281 N Cytarabine Idarubicin Vorinostat consolidation Created page with "==Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) consolidation== Preceded by Cytarabine_Idarubicin_Vorinostat_induction therapy. ===Regimen=== *[[Vorin..." current
- 03:5503:55, 9 October 2012 diff hist −116 m Vorinostat →Vorinostat (Zolinza) maintenance current
- 03:5303:53, 9 October 2012 diff hist +938 N Vorinostat Created page with "==Vorinostat (Zolinza) maintenance== Preceded by [[#Cytarabine_.28Cytosar.29.2C_Idarubicin_.28Idamycin.29.2C_Vorinostat_.28Zolinza.29_consolidation|Cytarabine (Cytosar), Idaru..."
- 03:5303:53, 9 October 2012 diff hist +19 Acute Myeloid Leukemia,Adult →Post-remission regimens
8 October 2012
- 03:0203:02, 8 October 2012 diff hist −50 m BEAC →Regimen current
- 03:0203:02, 8 October 2012 diff hist +1,121 N BEAC Created page with "BEAC: '''<u>B</u>'''iCNU, '''<u>E</u>'''toposide, '''<u>A</u>'''ra-C, '''<u>C</u>'''yclophosphamide ===Regimen === ''Autologous blood stem cells are infused on day 0.'' *[[Car..."
- 02:4902:49, 8 October 2012 diff hist +2,934 BEAM →Regimen current
- 02:0002:00, 8 October 2012 diff hist +107 m BEAM →Regimen
- 01:5201:52, 8 October 2012 diff hist −2 m BEAM →Regimen
- 01:4801:48, 8 October 2012 diff hist +1,010 N BEAM Created page with "===Regimen=== ''Day 0 is the day of transplantation.'' *Carmustine 300 mg/m2 IV on day -6 *Etoposide ) 200 mg/m2 IV BID on days -5 to -2 *Cytarabine ) 200 mg/m2 I..."
- 01:4601:46, 8 October 2012 diff hist +4 m Stem Cell Transplantation →Autograft regimens
- 01:4601:46, 8 October 2012 diff hist +19 Stem Cell Transplantation →Autograft regimens
- 01:3901:39, 8 October 2012 diff hist +33 Cytotoxic Regimens →External Links current
30 September 2012
- 03:4103:41, 30 September 2012 diff hist +47 m Main Page →Editors
27 August 2012
- 08:2708:27, 27 August 2012 diff hist +4 APL4 - ALLG →References current
- 08:2408:24, 27 August 2012 diff hist +4 m APL4 - ALLG →References
- 08:2408:24, 27 August 2012 diff hist +3,041 N APL4 - ALLG Created page with "== Regimen == '''Induction''' ATRA 45mg/m2/d PO Days 1-36 in divided doses Idarubicin 12mg/m2/d IV(ages 1-60) Days 2,4,6,and 8 9mg/m2/d IV (ages 61-70) 6mg/m2/d IV (ag..."
- 08:2308:23, 27 August 2012 diff hist 0 Acute Myeloid Leukemia,Adult →APL Regimens
- 08:1008:10, 27 August 2012 diff hist +20 Acute Myeloid Leukemia,Adult →APL Regimens
26 May 2012
- 23:3023:30, 26 May 2012 diff hist −1 m CLAG-M No edit summary current
- 23:2923:29, 26 May 2012 diff hist +443 ATRA plus As203 No edit summary current
- 23:2523:25, 26 May 2012 diff hist +4 m CLAG-M No edit summary
- 23:2423:24, 26 May 2012 diff hist +5 CLAG-M No edit summary
- 23:2423:24, 26 May 2012 diff hist +969 N CLAG-M Created page with "== Indication == Relapsed or refractory acute myeloid leukemia == Regimen == *Cladribine (2-CdA) 5 mg/m2/d iv over 2 hrs d1-5 *Cytarabine (Ara-C) 2 g/m2/d iv over 4 hrs star..."
- 23:2223:22, 26 May 2012 diff hist 0 m Acute Myeloid Leukemia,Adult →Salvage Regimens
- 23:2123:21, 26 May 2012 diff hist +4 m Acute Myeloid Leukemia,Adult →Salvage Regimens
- 23:2123:21, 26 May 2012 diff hist +11 Acute Myeloid Leukemia,Adult →Salvage Regimens
26 February 2012
- 10:0110:01, 26 February 2012 diff hist +65 FOLFIRINOX No edit summary current
- 10:0010:00, 26 February 2012 diff hist +1,094 FOLFIRINOX No edit summary
- 09:5809:58, 26 February 2012 diff hist +38 N FOLFIRINOX Created page with "== Metastatic Pancreatic Cancer =="
- 09:5709:57, 26 February 2012 diff hist +16 Pancreatic Cancer No edit summary current
23 February 2012
- 05:1505:15, 23 February 2012 diff hist −241 m VMP →Multiple Myeloma current
- 05:1405:14, 23 February 2012 diff hist +483 N VMP Created page with "== Multiple Myeloma == Bortezomib 1.3 mg/m2 IV or SC. Given subcutaneously or as a rapid IV bolus over three to five seconds. Days 1, 8, 15, and 22 Melphalan 9 mg/m2 PO dai..."
- 05:0805:08, 23 February 2012 diff hist +12 Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
20 February 2012
- 23:5923:59, 20 February 2012 diff hist +591 Cyclophosphamide Bortezomib Dexamethasone →Reference current
- 23:5523:55, 20 February 2012 diff hist +10 m Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
- 23:5423:54, 20 February 2012 diff hist +359 Cyclophosphamide Bortezomib Dexamethasone No edit summary
12 February 2012
- 21:4321:43, 12 February 2012 diff hist +10 MediaWiki:Sidebar No edit summary current
- 21:4121:41, 12 February 2012 diff hist −8 MediaWiki:Sidebar No edit summary
- 21:3921:39, 12 February 2012 diff hist −514 Main Page No edit summary
- 14:0414:04, 12 February 2012 diff hist 0 m Talk:Main Page Protected "Talk:Main Page" ([edit=sysop] (indefinite) [move=sysop] (indefinite)) current
- 14:0414:04, 12 February 2012 diff hist 0 m Main Page Protected "Main Page" ([edit=sysop] (indefinite) [move=sysop] (indefinite))
11 February 2012
- 10:3010:30, 11 February 2012 diff hist +176 N MediaWiki:Common.css Created page with "→CSS placed here will be applied to all skins: →Pad Google AdSense box in portlet in sidebar: #p-googleadsense .pBody { padding-top: 5px; text-align: center; }" current
- 10:1010:10, 11 February 2012 diff hist +7 m MediaWiki:Sidebar No edit summary
- 10:0910:09, 11 February 2012 diff hist +217 N MediaWiki:Sidebar Created page with " * navigation ** mainpage|mainpage-description // ** portal-url|portal ** currentevents-url|currentevents ** recentchanges-url|recentchanges ** randompage-url|randompage ** he..."
10 February 2012
- 22:0222:02, 10 February 2012 diff hist +1,382 m Main Page →Editors
7 February 2012
- 02:5902:59, 7 February 2012 diff hist −236 m Main Page →Welcome to Onco Wiki
- 02:3102:31, 7 February 2012 diff hist +336 N Weekly Carboplatin + Paclitaxel + RT → Carboplatin + Paclitaxel Created page with "== Indication == Concurrent chemoradiation for stage III cancer *Paclitaxel (Taxol) 45-50 mg/m2 iv over 1 h qw x 7 weeks *Carboplatin ACU 2 iv over 30 min qw x 7 weeks *Radio..." current
- 02:3102:31, 7 February 2012 diff hist +354 N Cisplatin + Etoposide + RT → Docetaxel Created page with "== Indication == Concurrent chemoradiation for stage III cancer *Cisplatin 50 mg/m2 iv days 1, 8, 29 and 36 *Etoposide (VP-16) 50 mg/2 iv days 1-5, 29-33 *Radiotherapy 1.8 Gy..." current
- 02:3002:30, 7 February 2012 diff hist −5 m Cancer treatment information No edit summary current
- 02:2702:27, 7 February 2012 diff hist −162 m Main Page No edit summary
- 02:2002:20, 7 February 2012 diff hist −2,993 Talk:Main Page Blanked the page
- 02:1902:19, 7 February 2012 diff hist +124 Guidelines for contributors No edit summary current
- 02:1802:18, 7 February 2012 diff hist −5 m Cytotoxic Regimens →Sections
- 02:1802:18, 7 February 2012 diff hist 0 m XELOX + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m XELIRI + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VeIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VNCOP-B 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VMPT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Unknown Primary, Carcinoma Of 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m TrophoblasticTumors, Gestational 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Total Therapy 2 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Total Therapy 1 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Topotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Thymoma And Thymic Carcinoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Thal/Dex 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Testicular Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Test spam 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temsirolimus 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + Thalidomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + IL-2 + IFN + GM-CSF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + IFN 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Tamoxifen 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m TIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sunitinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Streptozocin + Doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Streptozocin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Stem Cell Transplantation 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Stanford V 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Standard BEACOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Standard3plus7 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sorafenib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Satraplatin + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sarcoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sandbox 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m SMILE 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Rituximab, Bendamustine, Bortezomib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Rituximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Rev/Dex 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RTOG study 93-10 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RICE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-MCP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-GemOx 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-FCM + maintenance R 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-FCM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-EPOCH 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-CVP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-CHOP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Prostate Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Postremission High Dose Cytarabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Plerixafor and G-CSF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pentostatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pegylated liposomal doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Panitumumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pancreatic Cancer 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel IV + Cisplatin IP + Paclitaxel IP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel + Carboplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PCV 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PCR 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PAC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Oxaliplatin + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ovarian Epithelial Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Octreotide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Oblimersen + Dacarbazine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Non-Hematological Malignancies 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Nilotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Nasopharyngeal Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Myelodysplastic Syndromes 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Multiple Myeloma And Plasma Cell Dyscrasias 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Mitoxantrone + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Mini-BEAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MiCMA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Melanoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Megestrol acetate 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Malignant Mesothelioma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Main Page 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m MVAC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MRC UKALL XII/ECOG E2993 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MPT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MOPPABV Hybrid 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MINE/ESHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MIME 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MCP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MAID 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MACOP-B 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m M-BACOD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lymphoma Non-Hodgkin's, Adult 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Lymphoma Hodgkin's, Adult 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Luprolide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lung Cancer Small Cell 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lung Cancer Non Small Cell 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Linker Regimen 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lenalidomide + Rituximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lenalidomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LV + 5-FU + Irinotecan + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LV5FU-P 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LALA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Kidney Renal Cell Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ketoconazole 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Kaposi's Sarcoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Imatinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ifosfamide + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ifosfamide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IVE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IMVP-16 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IL-2 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IFL + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ICE-aml 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ICE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HyperCVADHDMTX-AraC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HyperCVAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m High dose Methotrexate 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hepatocellular Cancer Adult, Primary 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hematological Malignancies 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hairy Cell Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Guidelines on using this site 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Guidelines for contributors 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Goserelin + Flutamide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Goserelin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemtuzumab Ozogamicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Oxaliplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Erlotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Cisplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + 5-FU + RT 1 revision current